Company Sentisearch, Inc. Other OTC

SentiSearch Inc intends to develop and market insecticides for insect-borne disease control, as well as the insect repellent and agricultural crop protection marketplaces. The Company holds the rights to the olfaction intellectual property assets and certain applications titled Nucleic Acids and Proteins of Insect OR83b odorant receptor genes. The olfaction intellectual property assets can be used in Odorant receptors; cloning of vertebrate pheromone receptors, and genes encoding insect odorant receptors and their uses. The Company's gene modification process applications focus on the isolation of genes that are ubiquitous among insects. In collaboration with Bayer CropScience, the Company is developing solutions to control and eradicate insect-borne diseases, such as malaria and dengue fever.